SCHEMBL6207080

SCHEMBL6207080

N#CCC=CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6580156 1.00
SCHEMBL818468 0.83
SCHEMBL818467 0.83
SCHEMBL819793 0.83
SCHEMBL16369047 0.73 TSHR (0.53)
SCHEMBL9882909 0.73
SCHEMBL8273303 0.73
SCHEMBL7230172 0.71
SCHEMBL5311436 0.71
SCHEMBL13660116 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317466-B1 SYNTHONS FOR OLIGONUCLEOTIDE SYNTHESIS AVECIA BIOTECHNOLOGY INC (US) 2005-02-23 EP claimed
CN-115315430-A Nucleic acid synthesis method using segmented phosphoramidite compound 日东电工株式会社 2022-11-08 CN disclosed
WO-2021141072-A1 NUCLEIC ACID SYNTHESIS METHOD USING SEGMENT-TYPE AMIDITE 日東電工株式会社 2021-07-15 WO disclosed
CN-111668549-B Additive for electrolyte, electrolyte and battery material 广州天赐高新材料股份有限公司 2021-07-06 CN disclosed
CN-111668549-A Additive for electrolyte, electrolyte and battery material 广州天赐高新材料股份有限公司 2020-09-15 CN disclosed
CN-111479818-A Method and system for synthesizing oligonucleotides 深圳华大生命科学研究院 2020-07-31 CN disclosed
CN-111187797-A Method for synthesizing nucleic acids having a predetermined sequence 深圳华大生命科学研究院 2020-05-22 CN disclosed
EP-1317466-B1 SYNTHONS FOR OLIGONUCLEOTIDE SYNTHESIS AVECIA BIOTECHNOLOGY INC (US) 2005-02-23 EP disclosed
EP-0948512-B1 METHOD OF SYNTHESIZING PHOSPHOROTHIOATE OLIGONUCLEOTIDES ISIS PHARMACEUTICALS INC (US) 2004-10-06 EP disclosed
US-6780989-B2 HYBRID OLIGONUCLEOTIDE ISIS PHARMACEUTICALS, INC. 2004-08-24 US disclosed
US-5705621-A Oligomeric phosphite, phosphodiester, Phosphorothioate and phosphorodithioate compounds and intermediates for preparing same ISIS PHARMACEUTICALS, INC. (US) 1998-01-06 US disclosed
US-5637751-A REACTING IN LIQUID PHASE 2-BUTENE-1,4-DIOL AND/OR 3-BUTENE-1,2-DIOL WITH HYDROGEN CYANIDE IN PRESENCE OF MOLTEN CATALYST COMPRISING CUPROUS CHLORIDE OR BROMIDE AND NON-AROMATIC AMINE HYDROHALIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-06-10 US disclosed
WO-1997019092-A1 IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 1997-05-29 WO disclosed
EP-0612720-B1 Process for producing 1,4-dicyano-2-butene SUMITOMO CHEMICAL CO (JP) 1997-01-08 EP disclosed
EP-0563859-B1 Process for producing 1,4-dicyano-2-butene and catalyst therefor SUMITOMO CHEMICAL CO (JP) 1996-09-11 EP disclosed
EP-0702003-A2 Process for preparing 2-halogenpyridinaldehydes and new 2-halogenpyridinaldehydes BAYER AG (DE) 1996-03-20 EP disclosed
US-5463103-A Reacting butene derivative with hydrogen cyanide in presence of catalyst prepared from cuprous halide, lower alkylamine hydrohalide and Lewis acid or basic acetate, carbonate or bicarbonate SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-10-31 US disclosed
CN-1104630-A Process for producing 1,4-dicyano-2-butene SUMITOMO CHEMICAL CO (JP) 1995-07-05 CN disclosed
EP-0612720-A1 Process for producing 1,4-dicyano-2-butene SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1994-08-31 EP disclosed
EP-0563859-A2 Process for producing 1,4-dicyano-2-butene and catalyst therefor SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-10-06 EP disclosed